Healthcare at a
Turning Point
CEO Forum 2023 convenes at one of the most difficult political and economic moments of the past three decades. While health systems continue to struggle to fully recover from the pandemic, a global storm of economic, political and climate instability is creating a fresh stream of challenges for governments and businesses alike.
Our new format CEO Forum brings together international experts and health fund CEOs from across the world to debate the issues and explore the opportunities that will enable our industry to create innovative solutions to our shared challenges.
• The Global Economic & Political Outlook
• Sustainability
• Digital Security
• Human Capital
• Genomics
• Future of Cancer
• New Models of Collaboration
• Population Health
The ageless city of Athens – seat of ancient learning and modern medicine – offers the backdrop to the Forum. The Four Seasons Astir Palace provides the world-class venue where the meeting will take place.
CEO Forum 2023 commences on the evening of Monday 3 April with a welcome reception and concludes with departures after breakfast on Thursday 6 April. Partners are welcome to join you for the Forum’s social programme and your stay in Athens can be extended as your itinerary requires.
We are pleased to announce the first of our global experts who will be leading the debate in Athens. Watch out for more announcements in the coming days.
Swiss Re (Switzerland)
The Global Geopolitical & Geoeconomic Landscape
Jérôme Jean Haegeli is an internationally recognised economist known for his expertise in the performance of insurance markets as well as his contribution to the global policymakers’ dialogue. We are fortunate to have Jérôme lead our opening session on the changing nature of the global geopolitical and geoeconomic landscape in which we all operate.
Institute for Healthcare Improvement (UK)
Population Health
Pedro Delgado oversees IHI’s work in Latin America, Europe and Australasia, as well as the IHI Open School. Based in the United Kingdom, he is a driving force in IHI’s work in improving child cancer care around the world, as well as reducing C-sections and healthcare-acquired infections in Brazil and several Latin American countries, improving early-years education in Chile, improving patient safety in Portugal and mental health in the UK. Pedro will lead our discussion on achieving meaningful change in Population Health.
ENISA (Greece)
Digital Security
The European Union Agency for Cybersecurity (ENISA) is the EU’s agency dedicated to achieving a high common level of cybersecurity across Europe. Dr. Ouzounis leads ENISA’s efforts in implementing NIS Directive (NISD) 1 & 2, helping the Commission and Member States achieve a high level of cybersecurity at a macro and industry level. He will lead our discussion about the ever-changing nature of cyber threat.
BCollaborative (US)
UCB (US)
New Models of Collaboration
Lili Brillstein is a nationally recognised leader in promoting the migration from provider-focused, fee-for-service to patient-centered, fee-for-quality payment models. Donna Finale leads US health market sustainability at UCB. Together they bring deep knowledge to our discussion about implementing new models of collaboration that dramatically improve quality while reducing cost in the delivery of healthcare.
HCA
Future of Cancer
HCA is one of the world’s largest private healthcare providers, comprising 182 hospitals and 2,300 sites of care in the US and Europe. With a particular focus on cancer care, HCA has long been recognised as a leading innovator in cancer therapy development and care delivery.
Nuala has spent her career at the forefront of cancer care, first in the NHS specialising as a cancer nurse, and then at the London Clinic, where she was deputy chief executive and director of nursing care. Today, Nuala leads HCA’s Cancer Care business, working with specialists and payers to create ‘best in world’ experiences for their patients.
European Center of Pharmaceutical Medicine at University of Basel / Professor of Pharmaceutical Medicine / Co-Head Genomic Medicine / Chairman at University of Basel / Hirslanden Hospital / Helsana Insurance Group
What’s next in Genomic Medicine?
Among his many appointments, Thomas Szucs is Professor and Director of the European Center of Pharmaceutical/Institute of Pharmaceutical Medicine at the University of Basel, Switzerland.
In Athens, Professor Szucs will offer an insight into the future of genomic therapy and cancer, and lead a discussion on the key developments that payers need to be aware of in this critical area.
Forum for the Future
Sustainability
Forum for the Future is a leading global sustainability non-profit. For over 25 years the Forum has worked in partnership with business, governments and civil society to accelerate the shift toward a sustainable future.
Hannah leads the Forum’s European strategy, implementing initiatives that transform global systems to achieve a sustainable future. Hannah is an expert at using futures scenarios to understand the risks and opportunities that our likely future presents, using systems change practices to help navigate complex challenges.
